Robertson Wellness and Aesthetics in Beverly Hills, California, sits at the intersection of physician-overseen wellness services and wider interest in weight management. For readers searching for 'semaglutide los angeles Robertson Wellness,' the business story requires separating the clinic's stated services from national drug-use figures and global market projections that do not establish local demand or confirm a particular medication's availability.

A Robertson Boulevard Clinic With a Broad Wellness Menu

Established around 2021, Robertson Wellness and Aesthetics is located at 150 N Robertson Blvd Suite 206, Beverly Hills, CA, 90211. Its description identifies it as a Beverly Hills IV therapy and wellness clinic offering NAD+, ozone, peptides, weight management and aesthetics under physician oversight. That description places weight management within a broader collection of services rather than presenting the business solely through that category. The distinction matters to the scope of this article: the verified business information describes several areas of activity, but it does not identify a particular weight-management medication, provide treatment prices or name individual clinicians.

The website also lists an IV Membership, special offers at RWA, frequently asked questions and an Instagram connection. Those items accompany its service listings and invitation to book a consultation. The available business information supplies a location and direct contact channels: +1-310-407-0542 and info@rwacenter.com. It does not provide membership terms, the content of individual offers or a detailed explanation of each listed service. Consequently, the business profile is specific about the categories Robertson Wellness and Aesthetics names, while leaving unreported details unfilled. Its approximate establishment date also should not be treated as an exact opening date.

Why Beverly Hills Cannot Inherit Global Semaglutide Growth Figures

The broader market provides context, but not a Beverly Hills sales estimate. Grand View Research's Semaglutide Market Size, Share & Trends Report, 2026–2035 estimates the global semaglutide market at $34.6 billion in 2025 and projects compound annual growth of 9.8% during 2026–2035. Those supplied figures describe a worldwide medication market; they do not measure Robertson Wellness and Aesthetics, Beverly Hills clinics or Los Angeles patient spending. No Beverly Hills– or Robertson-specific semaglutide market size or growth rate for 2026 was verified in the supplied material. For a separate, primary-source route into broader business conditions, the U.S. Census Bureau's Business & Economy resources provide economic context, not substantiation for the semaglutide forecast. The analytical boundary is important: applying a global growth projection to a single local provider would create an appearance of precision without a local denominator. Even an expanding worldwide market cannot establish whether one clinic's consultations, revenue or treatment activity increased.

A second indicator measures something different. Gallup's In U.S., GLP-1 Usage Reaches New High reports that 11% of U.S. adults used GLP-1 medications for weight loss in 2026. That is a national, broader drug-class measure, not a semaglutide-only figure and not a Beverly Hills usage rate. Read alongside the global estimate, it illustrates why interest in weight management deserves business coverage while also showing why the measures cannot be combined into a local forecast. One concerns market value; the other concerns reported use among adults. Neither establishes which medication a particular practice offers. The U.S. Bureau of Labor Statistics is a primary source for a different part of an economic assessment—labor conditions—but is not the source of either drug-market figure cited here. For Beverly Hills coverage, the responsible conclusion is limited: national usage and global projections supply context, while local commercial performance remains unmeasured in the available material. A search phrase can indicate the subject a reader wants to understand; it cannot serve as evidence of a clinic's prescribing activity or its share of a market.

Weight Management Alongside IV Therapy at Robertson Wellness

Robertson Wellness and Aesthetics lists weight management alongside IV therapy, NAD+, ozone, peptides and aesthetics, with physician oversight included in its description. Its website also identifies an IV Membership and special offers at RWA, without terms supplied in the verified information. A consultation is the stated booking option. These are the service and access details available for this profile; the supplied business facts do not specify a semaglutide program, a medication formulation, eligibility criteria, appointment frequency or treatment outcomes. Keeping the description at that level preserves the difference between an advertised service category and the particulars of an individual treatment. The clinic's published contact details are +1-310-407-0542 and info@rwacenter.com, and its listed address is Suite 206 at 150 N Robertson Blvd in Beverly Hills.

The resulting picture is of a Beverly Hills wellness business whose stated offering includes weight management, situated within a much broader discussion of medication demand. That context warrants attention without turning national figures into neighborhood findings or treating a search query as a confirmed service listing. Readers can identify the clinic's location, named service categories and consultation invitation from the available information; questions beyond those facts remain unanswered by this profile. Business and consultation information is available at rwacenter.com.

Further reading from The Capital Front: Healthy Harmony’s Weight-Loss Offering and Daytona Beach’s Semaglutide Search and TruVive Clinic and Charlotte’s Medical Weight Loss Information Gap.